Thromboangiitis Obliterans
8 clinical trials · Condition
◉ Watch Thromboangiitis Obliterans
| Record | Firm | Date |
|---|---|---|
| Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI) (NCT02501018) | Lisata Therapeutics, Inc. | 2017-11-01 |
| Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia (NCT02864654) | Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation | 2016-07-01 |
| Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia (NCT02089828) | Shanghai Zhongshan Hospital | 2014-03-01 |
| Treatment of Thromboangiitis Obliterans (Buerguer's Disease) With Bosentan (NCT01447550) | Hospital Universitario Getafe | 2009-01-01 |
| ADDICTAO: Psychological and Addictive Profile of Patients With Buerger's Disease (NCT01064206) | University Hospital, Lille | 2008-09-01 |
| Individual Patient Expanded Access IND for Selexipag (Uptravi) in Participants With Non-healing Wound, Buerger's Disease (NCT04914247) | Actelion |
Track Thromboangiitis Obliterans automatically
Every clearance here is in the API, with alerts when new ones post.